baber/WOPTO huggingface dataset:
Patent DK-0817863-T3 (DK)
Inventor: GUADLIANA MARK A
IPC: C12N1/14
Filed: 1995-03-30
Granted: 1999-12-20
Abstract: PCT No. PCT/IB95/00217 Sec. 371 Date Aug. 13, 1997 Sec. 102(e) Date Aug. 13, 1997 PCT Filed Mar. 30, 1995 PCT Pub. No. WO96/30538 PCT Pub. Date Oct. 3, 1996Processes for preparing spirolaxine and spirolaxine methyl ether, the compounds of formulas (I) and (II) respectively, comprising fermenting fungi selected from the group consisting of Sporotrichum pruinosum FD 29585, ATCC 74327; Sporotrichum pruinosum FD 29454, ATCC 74329; Sporotrichun pruinosum FD 29586, ATCC 74328; and Phanerochaete chrysosporiun LN 3576, ATCC 74326. This invention also relates to a process for preparing spirolaxine comprising fermenting Sporotrichum pruinosum FD 29458, ATCC 74330.
Patent DK-0754071-T3 (DK)
Inventor: RUDZENA WILLIAM L
IPC: A61M16/14
Filed: 1995-03-30
Granted: 2002-12-02
Abstract: A system is provided for the delivery of a liquid anesthetic agent ti ab anesthetic vaporizer. The system includes a supply container having a spout defining an outlet through which the agent can be discharged. A reservoir is provided in the vaporizer for holding the agent, and a receiving station is provided on the vaporizer for receiving the container spout. The agent flows from the container through the spout by gravity into the reservoir. The container spout is located at the station to define the maximum liquid level of the agent in the vaporizer when gas flow into the container is blocked by the rising level of the liquid agent. In one embodiment, a frangible seal is provided in the container, an outlet valve is provided in the container, and an inlet valve is provided in the receiving station. The valves open automatically as the container is inserted into the receiving station of the vaporizer. Also, the container spout is preferably movable relative to a collar so as to automatically effect rupture of the frangible membrane as the container is inserted into the receiving station of the vaporizer.
Patent DK-0790807-T3 (DK)
Inventor: FREY RUDOLPH W
IPC: A61B19/00
Filed: 1995-04-18
Granted: 2001-10-08
Abstract: A method and system are provided for eroding or ablating a shaped volume of an eye's corneal tissue (10) in accordance with the treatment of a specified eye condition. To determine the laser beam shot pattern, a plurality of laser beam shots of uniform intensity are first selected to form a uniform shot pattern of uniform shot density. The laser beam shots applied in accordance with the uniform shot pattern of uniform shot density would be capable of eroding a volume of the corneal tissue (10) of uniform height. The volume of uniform height is approximately equivalent to that of the shaped volume. The laser beam shots are applied to the corneal tissue in a spatially distributed pattern spread over an area approximately equivalent to the surface area of the shaped volume to be eroded. The spatially distributed pattern extends the uniform shot pattern in fixed angles from a reference position on the shaped volume representative of the shaped volume's axis of symmetry. Shot density for the laser beam shots changes in correspondence with distance from the reference position.
Patent DK-0765154-T3 (DK)
Inventor: HOLLENBERG DETLEF
IPC: C09K23/44
Filed: 1995-06-07
Granted: 1999-09-13
Abstract: The invention concerns direct-acting hair colouring agents which contain a cationic polymer, a given  alpha -hydroxy acid and an ether-carboxylic acid.
Patent DK-0726322-T3 (DK)
Inventor: SUNDREHAGEN ERLING
IPC: C12Q1/48
Filed: 1993-01-22
Granted: 2003-07-28
Abstract: There is provided a method for assaying homocysteine in a sample, e.g. blood, plasma or urine, which comprises the steps of contacting said sample with a homocysteine converting enzyme other than SAH-hydrolase and at least one substrate for said enzyme other than homocysteine, and without chromatographic separation assessing a non-labelled analyte selected from a homocysteine co-substrate and the homocysteine conversion products of the enzymic conversion of homocysteine by said enzyme.
Patent DK-0799573-T3 (DK)
Inventor: MESSERLI ALFRED
IPC: A23L5/00
Filed: 1996-04-01
Granted: 2003-10-13
Abstract: Powder and liquid mixing procedure comprises sprinkling the powder on the liquid under a pressure of 1-10 bars and at a temperature of 10-90 degrees C, leaving the mixture to dissolve and extracting the air. Apparatus for carrying out the process comprises a vertical pipe (1) for delivering the powdered material (2), and a coaxial nozzle (3) for delivering the liquid, equipped with between 50 and 100 outlets. It has a mixing tube (4) with staggered ribs (6), and a receiving column (5) with a deflector plate (7), an air extraction tube (8) situated beneath the plate, and a curved outlet tube (9) for the solution. The air extraction tube has a toothed lower edge and is connected directly to a pump with automatic level control.
Patent DK-0743258-T3 (DK)
Inventor: ROJNIK MIROSLAV
IPC: B65D35/02
Filed: 1996-06-27
Granted: 1998-08-10
Abstract: The semi-rigid transparent or translucent plastics packaging tube (1) has one previously flattened end (11) sealed by two consecutive folds (13,14). The other tube end (10) is sealed by a base (5) in the shape of a disc glued or crimped onto the tube. The flattened end which is sealed by two folds has a band or label stuck on its two surfaces. The flattened end also has a cut out forming a slot allowing the tube to be suspended. The label is provided with perforations facilitating its tearing.
Patent DK-0803522-T3 (DK)
Inventor: HAAS PETER DR
IPC: C08G18/10
Filed: 1997-04-10
Granted: 2000-05-08
Abstract: Preparation of polyurethane foam mouldings by reaction injection moulding involves reacting (A1) an isocyanate prepolymer containing 15-31 wt.% isocyanate (NCO) groups by reacting (i) a bifunctional isocyanate component of the diphenylmethane series and (ii) a polyol component with an average molecular weight of 62-1000 and functionality of 2.0 and (A2) a bifunctional isocyanate component of the diphenylmethane series with an NCO content of 28-33.6%, (B1) polyol component(s) with a functionality of 2-6 and average molecular weight of 2000-10000, (B2) polyol component(s) with a functionality of 3-8, preferably 4-6 and average molecular weight of 92-1999, (C) water and optionally organic blowing agent, (D) stabiliser and (E) known ancillaries and additives. The novel features are that (F) alkali carboxylates are used as activators with (G) compounds containing acid groups, with an acid number of 20-1000, preferably 20-500; and the polyol component (B2) contains tertiary nitrogen atom(s).
Patent DK-1015562-T3 (DK)
Inventor: TURK STEFANUS CORNELIS HENDRIK
IPC: A23L29/206
Filed: 1997-02-07
Granted: 2008-01-02
Abstract: The present invention relates to a method for manufacturing modified polysaccharides comprising of placing the polysaccharide in contact with a sugar group-transferring enzyme and a sugar group donor. The placing of the polysaccharide in contact with a sugar group-transferring enzyme and a sugar group donor can be effected in vivo as well as in vitro. The result of the method is modified polysaccharides which can be used for different food and non-food applications.
Patent DK-0952867-T3 (DK)
Inventor: CHERIF-CHEIKH ROLAND
IPC: A61K9/70
Filed: 1997-12-02
Granted: 2007-11-05
Abstract: The use of a specific device is claimed for implantation or insertion of a solid or semi-solid formulation (F), containing an active ingredient (A), into an organism at a precise receptor site. The device includes a component which is inserted into the body of the patient, can store (F) and can position (F) the precise site where it is required. The injection or insertion of (F) can be controlled externally. The device is withdrawn after (A) has been so placed. Formulations for use in the device are also claimed, specifically containing at least 50% of (A) mixed with a polylactide-glycolide copolymer (PGLA).
Patent DK-1045690-T3 (DK)
Inventor: CONNOR DAVID THOMAS
IPC: A61P25/28
Filed: 1998-11-04
Granted: 2003-08-04
Abstract: PCT No. PCT/US98/23482 Sec. 371 Date Feb. 7, 2000 Sec. 102(e) Date Feb. 7, 2000 PCT Filed Nov. 4, 1998 PCT Pub. No. WO99/26616 PCT Pub. Date Jun. 3, 1999The present invention provides compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of diseases whose treatment benefits from the inhibition of phosphodiesterase (PDE-IV) or Tumor Necrosis Factor (TNF) including asthma, allergic diseases, rheumatoid arthritis, osteoarthritis, septic shock. The compounds provided by this invention have formula (I) wherein R1, R2, R3, R4 are as defined herein.
Patent ES-2197051-T3 (ES)
Inventor: SEIFERT JOST
IPC: G01C23/00
Filed: 2000-11-13
Granted: 2004-01-01
Abstract: The display indicates the ground (3) as a checker-board pattern or three-dimensionally, the representation resulting from the relative position of the geodetic coordinate system XG, YG, ZG w.r.t the aerodynamic axis system. The ground may include orientation points for the pilot. The primary control surfaces of the aircraft and their instantaneous deflections may also be displayed.
Patent ES-2204445-T3 (ES)
Inventor: DAVIS BRUCE
IPC: H04N7/16
Filed: 1995-10-27
Granted: 2004-05-01
Abstract: A method for determining whether one or more of a plurality of data fields for a plurality of television stations of a database that stores program schedule information for an electronic program guide contains missing or invalid data characterised by: 
allowing a user to select a station from the plurality of stations for verification of at least one of the data fields for the selected station; 
allowing the user to select a time range for the verification of the data fields; 
automatically analysing the data fields for the selected station for errors, wherein the errors are comprised of invalid or missing data; 
listing the detected errors; and 
providing the user with the ability to correct the detected errors.
Patent ES-2186624-T3 (ES)
Inventor: PATIL ABHIMANYU ONKAR
IPC: C08G67/02
Filed: 2000-01-14
Granted: 2003-05-16
Abstract: The invention relates to a method of forming carbon monoxide-containing polymers from multi-component syngas feeds and at least one vinyl comonomer. Feeds useful in the practice of the invention comprise ethylene in an amount ranging from about 5 to about 40 mole %, carbon monoxide is an amount ranging from about 1 to about 40 mole %, hydrogen in an amount ranging from about 4 to about 55 mole %, carbon dioxide in an amount ranging from about 3 to about 10 mole %, and methane in an amount ranging from about 4 to about 85 mole %. The feed may also include acetylene in an amount ranging up to about 10 mole %. The feed may contain at least one free radical-polymerizable vinyl comonomer, or a cofeed containing such a comonomer can be used.
Patent ES-2255977-T3 (ES)
Title: Utilizacion de un compuesto farmaceutico que contiene desoxipeganina para el tratamiento de la dependencia a la nicotina.
Inventor: ASMUSSEN BODO
IPC: A61K31/519
Filed: 2000-02-08
Granted: 2006-07-16
Abstract: Utilización de un compuesto farmacéutico que contiene desoxipeganina para el tratamiento de la dependencia a la nicotina. La presente invención se refiere a la nueva aplicación de un principio activo poco conocido para el tratamiento de la dependencia a la nicotina. En particular, la presente invención se centra en la utilización farmacéutica en formulaciones mediante las cuales se emite desoxipeganina o una de sus sales de adición ácida, farmacéuticamente aceptable, para el tratamiento de la dependencia a la nicotina, de forma controlada y, por ejemplo, continua.
Patent ES-2206202-T3 (ES)
Title: Uso de xenon para preparar una preparacion farmaceutica para tratar neurointoxicaciones.
Inventor: PETZELT CHRISTIAN
IPC: A61P25/00
Filed: 2000-03-08
Granted: 2004-05-16
Abstract: Uso de xenón o mezclas de gas xenón para preparar una preparación farmacéutica para tratar neurointoxicaciones, caracterizado porque la neurointoxicación está provocada por un exceso de neurotransmisores. El xenón reduce la liberación de dopamina, glutamato y/o noradrenalina. La neurointoxicación está provocada por una apoplejía; por un abuso de drogas; por deficiencia de oxígeno durante el nacimiento; por un trauma craneocerebral; se correlaciona con enfermedad de Parkinson, esquizofrenia o síndrome de Gilles de la Tourette.
Patent ES-2326257-T3 (ES)
Inventor: GENNARO MARIA L
IPC: A61K48/00
Filed: 2000-05-04
Granted: 2009-10-06
Abstract: The invention provides polypeptides encoded by open reading frames present in the genome of  Mycobacterium tuberculosis  but absent from the genome of BCG and diagnostic and prophylactic methodologies using these polypeptides.
Patent ES-2260018-T3 (ES)
Title: Maquina de rodillos de flexion.
Inventor: COTTEVERTE PATRICK
IPC: A21C11/04
Filed: 2000-05-03
Granted: 2006-11-01
Abstract: Máquina de rodillos de flexión (10), con varios cilindros de moldeo (11, 12, 13) alineados paralelos entre sí, para la formación de productos de piezas pequeñas a partir de una sección de colada continua, en la que los cilindros de moldeo (11, 12, 13) están fijados en elementos de cojinetes (26, 27), que se pueden fijar de una manera sustituible en alojamientos (32) de la máquina de rodillos de flexión (10), con un primer motor de accionamiento (15) para la rotación de los cilindros de moldeo (11, 12, 13) alrededor de sus ejes longitudinales, caracterizada porque está previsto un segundo motor de accionamiento (38) para la rotación de uno de los cilindros de moldeo (13) con relación a los otros cilindros de moldeo (11, 12), y porque el primer motor de accionamiento (15) está acoplado por medio de elementos articulados (18, 19, 20) con los cilindros de moldeo (11, 12, 13).
Patent ES-2278623-T3 (ES)
Title: Embrague.
Inventor: NEUWIRTH ERNST
IPC: F16D11/16
Filed: 2000-07-13
Granted: 2007-08-16
Abstract: Embrague que comprende dos piezas (1, 2) dispuestas en forma móvil una respecto de otra, de las cuales una está provista de varias muescas (3a) y la otra está provista de al menos una superficie de tope (5, 13, 22) vuelta hacia las muescas (3a), y al menos un cuerpo de bloqueo (6, 20, 21) que une las dos piezas (1, 2) una con otra bajo ajuste de forma al, por un lado, encajar en al menos una de las muescas (3a) y, por otro lado, aplicarse a la superficie de tope (5, 13, 22), y un espacio libre (12) previsto para el cuerpo de bloqueo (6, 20, 21), en el que dicho cuerpo de bloqueo (6, 20, 21) está desacoplado de la muesca (3a), caracterizado por un embragador desplazable (9) que ataca en el cuerpo de bloqueo (5, 20, 21) para desplazar dicho cuerpo de bloqueo (6, 20, 21) hacia fuera del espacio libre (12) y hacia dentro de la muesca (3a), y por un desembragador (8, 15, 19) que ataca en el cuerpo de bloqueo (6, 20, 21) para desplazar dicho cuerpo de bloqueo (6, 20, 21) hacia fuera de la muesca(3a) y hacia dentro del espacio libre (12).
Patent ES-2262561-T3 (ES)
Title: Dispositivo de detonacion, especialmente para una granada de mortero.
Inventor: ZEHNDER WOLFGANG
IPC: F42C15/295
Filed: 2001-01-03
Granted: 2006-12-01
Abstract: Dispositivo de detonación (14) para una granada de mortero (10), que puede ser desplazado de posición de seguro a una posición de armado por medio de un dispositivo de muelle (74), presentando el dispositivo de detonación (14) un molinete para quitar el seguro de una carcasa desplazable (16) de un dispositivo de seguro, inmovilizada en la posición de seguro y dotada de un detonador (94), así como un primero y un segundo bulones (76, 78) de retirada del seguro, estando prevista una chapa de seguro entre un árbol de molinete unido con el molinete y el segundo bulón de retirada del seguro, caracterizado porque el árbol (24) del molinete está acoplado para transmisión de pares de giro, en la posición de seguro, con un tornillo sinfín (30) que está operativamente unido con un casquillo dentado (44) de un mecanismo de retirada del seguro, por medio del cual la carcasa (16) del dispositivo de seguro puede ser liberada por el árbol (54) de retirada del seguro hacia una posición de seguro al pie dela boca del cañón, y porque el mecanismo de retirada del seguro presenta una rueda accionada (68) que está prevista para pretensar el dispositivo de muelle (74) a fin de desplazar la carcasa (16) del dispositivo de seguro desde la posición de seguro hasta la posición de armado.
Patent ES-2280278-T3 (ES)
Inventor: HAUNER FRANZ DR
IPC: H01H1/02
Filed: 2001-03-01
Granted: 2007-09-16
Abstract: Chromium powder, alone or as a mixture, and with the required final weight of chromium, is mixed with copper powder, its weight being 5-15 wt% deficient in comparison with the copper content of the final contact material. Pressing takes place at 200-1000 MPa, forming a porus blank having 75%-90% of the theoretical density. This is coated with sufficient copper to make up the deficit. In high vacuum, heating takes place to or above the melting point of copper, sintering to a chromium- or copper-chromium matrix, impregnated with copper from the coating. At this stage the copper content is increased beyond that of the pressing and the density is 96%-98% of theoretical. Deformation by at least 30%, during extrusion with directed extension follows, drawing the chrome to filaments in the direction of extension, to form a directed structure. The unfinished contact blank material then has at least 99%, especially 99.5%-99.9 %, of the theoretical density. An INDEPENDENT CLAIM is included for the corresponding contact component. Its tensile strength and electrical conductivity parallel to extension are each at least 10% greater than in the transverse direction.
Patent ES-2230200-T3 (ES)
Title: Dispositivo para la administracion de un agente terapeutico.
Inventor: STEG HENNING
IPC: A61M5/158
Filed: 2001-05-09
Granted: 2005-05-01
Abstract: Dispositivo de infusión (10) para la administración de un agente terapéutico (11) al interior del cuerpo de un humano o de un animal que comprende al menos un primer elemento (12), en el que se ha dispuesto una cánula (13) para su introducción en el interior del cuerpo y alojamiento dentro del cuerpo y un segundo elemento (14) que presenta una aguja (15) con un hueco continuo (16) del tipo de una aguja de inyección y que va unida a un elemento de tubo flexible (17) para el suministro del agente terapéutico (11), en el que el primer y el segundo elemento (12, 14) van conectados entre sí de forma separable fija mediante un elemento de encaje, de forma que el agente terapéutico (11) pueda llegar a la cánula (13) a través del elemento de tubo flexible (17) y la aguja (15), caracterizado porque el elemento de encaje está formado por una ranura perimetral esencialmente en forma de anillo circular (19) dispuesta en el segundo elemento (14) realizado en lo esencial axialmente simétrico (20) respecto a la aguja (15) y por al menos un elemento de garra (22) que en estado de acoplamiento se sitúa en el primer elemento (12) esencialmente en dirección ortogonal al segundo elemento (14), que puede desplazarse (21) hacia delante y hacia atrás y que en estado de acoplamiento de ambos elementos (12, 14) encaja en la ranura (19), enclavando entre sí los dos elementos (12, 14).
Patent ES-2227021-T3 (ES)
Inventor: BORZ FABIO
IPC: A47B96/14
Filed: 2001-06-20
Granted: 2005-04-01
Abstract: The U-profile (1) for building shelf support frames has bores (6) in its arms which are in the center of annular depressions (5) . The arms of a second, similar profile (2) can be inserted between the arms of the first, so that the depressions cooperate and they are held together by their resilience, producing a concave, convex or sloping deformation of the arms. An Independent claim is included for a connecting system for profiles as described above.
Patent ES-2231367-T3 (ES)
Inventor: PAWLAS AXEL F
IPC: G07F17/34
Filed: 2001-09-12
Granted: 2005-05-16
Abstract: A top section (10) has display devices (11) like rotating cylinders/disks/cubes/flip cards/symbols that are synchronized with the display devices on the gaming machines in a system of gaming machines and consequently display the same symbol combination. The gaming machines in the system each have a central control unit and are networked with each other. A central control unit also controls them jointly.
Patent ES-2260156-T3 (ES)
Title: Derivados de (imidazol-5-il)metil-2-quinolinona como inhibidores de la proteina farnesil-transferasa.
Inventor: VENET MARC GASTON
IPC: C07D405/14
Filed: 1996-10-16
Granted: 2006-11-01
Abstract: Un compuesto de fórmula (I) (Ver fórmula) una forma estereoisomérica del mismo, una sal de adición de ácido o de base del mismo farmacéuticamente aceptable en la que la línea de puntos representa un enlace opcional; X es oxígeno o azufre; R1 es hidrógeno, alquilo C1_12, Ar1, Ar2-alquilo C1-6, quinolinil-alquilo C1-6, piridil-alquilo C1-6, hidroxi-alquilo C1_6, alquiloxi (C1~6)-alquilo C1~6, mono- ó di(alquil C1_66)amino-alquiloC1-6, amino-alquilo C1-6 ó un radical de fórmula -Alk1-C(=O)-R9, -Alk1-S(O)-R9 ó -Alk1-S(O)2-R9, en la que Alk1 es alcanodiílo C1_6, R9 es hidroxi, alquilo C1_6, alquiloxi C1_6, amino, alquilamino C1_8 ó alquilamino C1_8 sustituido con alquiloxicarbonilo C1_6; R2, R3 y R16 son cada uno independientemente hidrógeno, hidroxi, halo, ciano, alquilo C1_6, alquiloxi C1_6, hidroxialquiloxi C1_6, alquiloxi (C1~6)-alquiloxi C1-6, amino-alquiloxi C1-6, mono- ó di(alquil C1~6)amino-alquiloxi C1-6, Ar1, Ar2-alquilo C C1-6, Ar2-oxi, , AAr2-alquiloxi C C1-6, hidroxicarbonilo, alquiloxicarbonilo C1-6, trihalometilo, trihalometoxi, alquenilo C2-6, 4, 4-dimetiloxazolilo; ó cuando en posiciones contiguas R2 y R3 tomados conjuntamente pueden formar un radical bivalente de fórmula -O-CH2O- (a-1) -O-CH2-CH2-O- (a-2) -O-CH=CH- (a-3) -O-CH2-CH2- (a-4) -O-H2-CH2-CH2- (a-5) ó -CH=CHCH=CH- (a-6); R4 y R5 son cada uno independientemente hidrógeno, halo, Ar1, alquilo C1-6, hidroxi-alquilo C C1-6, alquiloxi (C1-6)alquilo C1-6, alquiloxi C1-6, alquiltio C1-6, amino, hidroxicarbonilo, alquiloxicarbonilo C1-6, alquil (C1~6)-S(O)-alquiloC1-6 ó alquil (C1-6)-S(O)2-alquilo C1-6; R6 y R7 son cada uno independientemente hidrógeno, halo, ciano, alquilo C1-6, alquiloxi C1-6, Ar2-oxi, , trihalometilo, alquiltio C1-6, di(alquil C1~6)amino, o cuando en posiciones contiguas R6 y R7 tomados conjuntamente pueden formar un radical bivalente de fórmula -O-CH2-O- (c-1),
Patent ES-2240373-T3 (ES)
Title: Caja de control electronico para aparatos de cocina.
Inventor: BONNAFE JEAN-PASCAL
IPC: F24C7/08
Filed: 2001-09-27
Granted: 2005-10-16
Abstract: Dispositivo de control electrónico para aparatos de cocina, que comprende una electrónica "de potencia" que sirve para regular la alimentación con gas o electricidad de los fuegos de un aparato de cocina, caracterizado porque dicha electrónica (3) de potencia está situada en una caja que forma canal, durante la utilización, para una corriente de aire de refrigeración de esta electrónica (3), comprendiendo dicha caja uno o varios orificios (11) de entrada y uno o varios orificios (12) de salida para dicha corriente de aire, y que contiene, además, un ventilador (5) destinado a producir esta corriente de aire, estando situada la electrónica (3) a lo largo de dicho canal, entre dichos orificios (11) de entrada de aire y dicho ventilador (5).
Patent ES-2223816-T3 (ES)
Inventor: BEACH DAVID L
IPC: C08F4/02
Filed: 2001-03-16
Granted: 2005-03-01
Abstract: The present invention is directed to producing a resin which, when formed into a film, has excellent gas barrier and/or moisture barrier (low MVTR) properties. Further, the resin has a relatively high molecular weight distribution, preferably above 6, and has excellent processability/extrudability. The resin is produced using a cyclopentadienyl chromium compound, preferably a mono CpCr compound, on a support, preferably a silica support. A particularly preferred catalyst for use in the present invention comprises pentamethylcyclopentadienyidimethylchromiumpyridine. Preferably, the catalyst is used in a slurry polymerization process.